Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 301

1.

Low Systolic Blood Pressure and Mortality in Elderly Patients After Acute Myocardial Infarction.

Mouhat B, Putot A, Hanon O, Eicher JC, Chagué F, Beer JC, Maza M, Zeller M, Cottin Y; Observatoire des Infarctus de Côte d'Or Survey.

J Am Heart Assoc. 2020 Mar 3;9(5):e013030. doi: 10.1161/JAHA.119.013030. Epub 2020 Feb 26.

2.

Type 2 Myocardial Infarction: A Geriatric Population-based Model of Pathogenesis.

Putot A, Jeanmichel M, Chague F, Manckoundia P, Cottin Y, Zeller M.

Aging Dis. 2020 Feb 1;11(1):108-117. doi: 10.14336/AD.2019.0405. eCollection 2020 Feb.

3.

Influence of cardiac hemodynamic variables on retinal vessel density measurement on optical coherence tomography angiography in patients with myocardial infarction.

Arnould L, Guenancia C, Gabrielle PH, Pitois S, Baudin F, Pommier T, Zeller M, Bron AM, Creuzot-Garcher C, Cottin Y.

J Fr Ophtalmol. 2020 Mar;43(3):216-221. doi: 10.1016/j.jfo.2019.07.026. Epub 2020 Jan 20.

PMID:
31973975
4.

Growth Differentiation Factor-8 (GDF8)/Myostatin is a Predictor of Troponin I Peak and a Marker of Clinical Severity after Acute Myocardial Infarction.

Meloux A, Rochette L, Maza M, Bichat F, Tribouillard L, Cottin Y, Zeller M, Vergely C.

J Clin Med. 2019 Dec 31;9(1). pii: E116. doi: 10.3390/jcm9010116.

5.

Patient care pathways in acute heart failure and their impact on in-hospital mortality, a French national prospective survey.

Gorlicki J, Boubaya M, Cottin Y, Angoulvant D, Soulat L, Guinemer S, Bloch-Queyrat C, Deltour S, Lambert Y, Juillière Y, Adnet F.

Int J Cardiol Heart Vasc. 2019 Dec 5;26:100448. doi: 10.1016/j.ijcha.2019.100448. eCollection 2020 Feb.

6.

Brain-Heart Interactions During Ischemic Processes: Clinical and Experimental Evidences.

Méloux A, Béjot Y, Rochette L, Cottin Y, Vergely C.

Stroke. 2020 Feb;51(2):679-686. doi: 10.1161/STROKEAHA.119.027732. Epub 2019 Dec 20. No abstract available.

PMID:
31856693
7.

Type 1 or Type 2 Myocardial Infarction in Patients with a History of Coronary Artery Disease: Data from the Emergency Department.

Putot A, Jeanmichel M, Chagué F, Avondo A, Ray P, Manckoundia P, Zeller M, Cottin Y.

J Clin Med. 2019 Dec 2;8(12). pii: E2100. doi: 10.3390/jcm8122100.

8.

In-hospital outcomes and 5-year mortality following an acute myocardial infarction in patients with a history of cancer: Results from the French registry on Acute ST-elevation or non-ST-elevation myocardial infarction (FAST-MI) 2005 cohort.

Ederhy S, Cohen A, Boccara F, Puymirat E, Aissaoui N, Elbaz M, Bonnefoy-Cudraz E, Druelles P, Andrieu S, Angoulvant D, Furber A, Ferrières J, Schiele F, Cottin Y, Simon T, Danchin N; FAST-MI investigators.

Arch Cardiovasc Dis. 2019 Nov;112(11):657-669. doi: 10.1016/j.acvd.2019.06.012. Epub 2019 Nov 21.

PMID:
31761740
9.

Clinical patterns and significance of non-compliance with guideline-recommended treatment of acute pulmonary embolism.

Cart L, Serzian G, Humbert S, Falvo N, Morel-Aleton M, Bonnet B, Napporn G, Kalbacher E, Obert L, Cappelier G, Cottin Y, Schiele F, Meneveau N, Chopard R.

Arch Cardiovasc Dis. 2020 Jan;113(1):31-39. doi: 10.1016/j.acvd.2019.09.009. Epub 2019 Nov 2.

PMID:
31690519
10.

[Comparison of the prognostic value of different clinical, angiographic and scintigraphic scores in stable coronary patients after acute coronary syndrome].

Humbert O, Noirot E, Leclerc T, Mouhat B, Pommier T, Cochet A, Cottin Y.

Ann Cardiol Angeiol (Paris). 2020 Mar;69(1):12-23. doi: 10.1016/j.ancard.2019.07.016. Epub 2019 Sep 12. French.

PMID:
31522776
11.

Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for an acute myocardial infarction: Data from the French RICO survey.

Farnier M, Salignon-Vernay C, Yao H, Chague F, Brunel P, Maza M, Brunet D, Bichat F, Beer JC, Cottin Y, Zeller M.

J Clin Lipidol. 2019 Jul - Aug;13(4):601-607. doi: 10.1016/j.jacl.2019.06.005. Epub 2019 Jun 21.

PMID:
31324593
12.

Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS.

Blin P, Dureau-Pournin C, Bénichou J, Cottin Y, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N.

Am J Cardiovasc Drugs. 2020 Feb;20(1):81-103. doi: 10.1007/s40256-019-00359-z.

PMID:
31254174
13.

Post-Infectious Myocardial Infarction: New Insights for Improved Screening.

Putot A, Chague F, Manckoundia P, Cottin Y, Zeller M.

J Clin Med. 2019 Jun 11;8(6). pii: E827. doi: 10.3390/jcm8060827.

14.

The Role of Osteoprotegerin in Vascular Calcification and Bone Metabolism: The Basis for Developing New Therapeutics.

Rochette L, Meloux A, Rigal E, Zeller M, Malka G, Cottin Y, Vergely C.

Calcif Tissue Int. 2019 Sep;105(3):239-251. doi: 10.1007/s00223-019-00573-6. Epub 2019 Jun 13. Review.

PMID:
31197415
15.

Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarction according to use of reperfusion therapy: Data from the FAST-MI program 1995-2015.

Puymirat E, Cayla G, Cottin Y, Elbaz M, Henry P, Gerbaud E, Lemesle G, Popovic B, Labèque JN, Roubille F, Andrieu S, Farah B, Schiele F, Ferrières J, Simon T, Danchin N.

Am Heart J. 2019 Aug;214:97-106. doi: 10.1016/j.ahj.2019.05.007. Epub 2019 May 16.

PMID:
31181374
16.

Retinal Vascular Density as A Novel Biomarker of Acute Renal Injury after Acute Coronary Syndrome.

Alan G, Guenancia C, Arnould L, Azemar A, Pitois S, Maza M, Bichat F, Zeller M, Gabrielle PH, Bron AM, Creuzot-Garcher C, Cottin Y.

Sci Rep. 2019 May 30;9(1):8060. doi: 10.1038/s41598-019-44647-9.

17.

Cardiovascular prevention and at-risk behaviours in a large population of amateur rugby players.

Chagué F, Georges M, Gudjoncik A, Hermerel T, Garet G, Israël J, Hager JP, Aviat P, Laurent Y, Gremeaux V, Cottin Y, Zeller M.

Eur J Prev Cardiol. 2019 Sep;26(14):1522-1530. doi: 10.1177/2047487319837066. Epub 2019 Mar 19.

PMID:
30889980
18.

Glycaemic variability is associated with severity of coronary artery disease in patients with poorly controlled type 2 diabetes and acute myocardial infarction.

Benalia M, Zeller M, Mouhat B, Guenancia C, Yameogo V, Greco C, Yao H, Maza M, Vergès B, Cottin Y.

Diabetes Metab. 2019 Oct;45(5):446-452. doi: 10.1016/j.diabet.2019.01.012. Epub 2019 Feb 11.

PMID:
30763700
19.

The Role of Osteoprotegerin and Its Ligands in Vascular Function.

Rochette L, Meloux A, Rigal E, Zeller M, Cottin Y, Vergely C.

Int J Mol Sci. 2019 Feb 6;20(3). pii: E705. doi: 10.3390/ijms20030705. Review.

20.

Editorial.

Cohen A, Cottin Y, Juilliere Y; Editorial Committee.

Arch Cardiovasc Dis. 2019 Jan;112(1):1-2. doi: 10.1016/j.acvd.2018.08.003. Epub 2019 Jan 14. No abstract available.

21.

Prescription patterns of direct oral anticoagulants in pulmonary embolism: A prospective multicenter French registry.

Chopard R, Andarelli JN, Humbert S, Falvo N, Morel-Aleton M, Bonnet B, Napporn G, Kalbacher E, Obert L, Degano B, Cappelier G, Cottin Y, Schiele F, Meneveau N.

Thromb Res. 2019 Feb;174:27-33. doi: 10.1016/j.thromres.2018.12.013. Epub 2018 Dec 8.

PMID:
30553162
22.

Regenerative Capacity of Endogenous Factor: Growth Differentiation Factor 11; a New Approach of the Management of Age-Related Cardiovascular Events.

Rochette L, Meloux A, Rigal E, Zeller M, Cottin Y, Malka G, Vergely C.

Int J Mol Sci. 2018 Dec 12;19(12). pii: E3998. doi: 10.3390/ijms19123998. Review.

23.

Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation.

Blin P, Dureau-Pournin C, Cottin Y, Bénichou J, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N.

Clin Pharmacol Ther. 2019 Jun;105(6):1439-1455. doi: 10.1002/cpt.1318. Epub 2019 Feb 6.

PMID:
30499605
24.

Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillation.

Blin P, Dureau-Pournin C, Cottin Y, Bénichou J, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N.

Br J Clin Pharmacol. 2019 Feb;85(2):432-441. doi: 10.1111/bcp.13815. Epub 2018 Dec 16.

25.

The EYE-MI Pilot Study: A Prospective Acute Coronary Syndrome Cohort Evaluated With Retinal Optical Coherence Tomography Angiography.

Arnould L, Guenancia C, Azemar A, Alan G, Pitois S, Bichat F, Zeller M, Gabrielle PH, Bron AM, Creuzot-Garcher C, Cottin Y.

Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4299-4306. doi: 10.1167/iovs.18-24090.

PMID:
30372758
26.

Ischemic Stroke Increases Heart Vulnerability to Ischemia-Reperfusion and Alters Myocardial Cardioprotective Pathways.

Meloux A, Rigal E, Rochette L, Cottin Y, Bejot Y, Vergely C.

Stroke. 2018 Nov;49(11):2752-2760. doi: 10.1161/STROKEAHA.118.022207.

PMID:
30355197
27.

One-Year Survival After ST-Segment-Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy.

Danchin N, Puymirat E, Cayla G, Cottin Y, Coste P, Gilard M, Goldstein P, Braun F, Belle L, Montalescot G, Ferrières J, Schiele F, Simon T; FAST-MI Investigators.

Circ Cardiovasc Interv. 2018 Sep;11(9):e007241. doi: 10.1161/CIRCINTERVENTIONS.118.007241.

PMID:
30354592
28.

Incidence, Predictive Factors, and Prognostic Impact of Silent Atrial Fibrillation After Transcatheter Aortic Valve Implantation.

Robert R, Porot G, Vernay C, Buffet P, Fichot M, Guenancia C, Pommier T, Mouhat B, Cottin Y, Lorgis L.

Am J Cardiol. 2018 Aug 1;122(3):446-454. doi: 10.1016/j.amjcard.2018.04.029. Epub 2018 May 1.

PMID:
30201110
29.

High rate of recurrence at long-term follow-up after new-onset atrial fibrillation during acute myocardial infarction.

Guenancia C, Toucas C, Fauchier L, Stamboul K, Garnier F, Mouhat B, Sagnard A, Lorgis L, Zeller M, Cottin Y.

Europace. 2018 Dec 1;20(12):e179-e188. doi: 10.1093/europace/euy168.

PMID:
30060066
30.

Validity of ambulatory blood pressure monitoring in daily primary healthcare practice in France.

Mazalovic K, Morlon F, Beis JN, Duglet PE, Cottin Y, Zabawa C.

Blood Press Monit. 2018 Dec;23(6):288-293. doi: 10.1097/MBP.0000000000000342.

PMID:
30048256
31.

Could vagal tone increase explain the excess of bradycardia episodes during the last day of the long interdialytic interval?

Pugliesi PS, Guenancia C, Cottin Y, Rebibou JM.

Kidney Int. 2018 Aug;94(2):430. doi: 10.1016/j.kint.2018.05.011. No abstract available.

PMID:
30031448
32.

Predictors of angiographically visible distal embolization in STEMI.

Yaméogo NV, Guenancia C, Porot G, Stamboul K, Richard C, Gudjoncik A, Hamblin J, Buffet P, Lorgis L, Cottin Y.

Herz. 2018 Jun 20. doi: 10.1007/s00059-018-4723-1. [Epub ahead of print]

PMID:
29926119
33.

Thirty-day rehospitalizations among elderly patients with acute myocardial infarction: Impact of postdischarge ambulatory care.

Zabawa C, Cottenet J, Zeller M, Mercier G, Rodwin VG, Cottin Y, Quantin C.

Medicine (Baltimore). 2018 Jun;97(24):e11085. doi: 10.1097/MD.0000000000011085.

34.

Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse events.

Chopard R, Serzian G, Humbert S, Falvo N, Morel-Aleton M, Bonnet B, Napporn G, Kalbacher E, Obert L, Degano B, Cappelier G, Cottin Y, Schiele F, Meneveau N.

J Thromb Thrombolysis. 2018 Oct;46(3):283-291. doi: 10.1007/s11239-018-1690-6.

PMID:
29869319
35.

Short-Term Prognosis of Myocardial Injury, Type 1, and Type 2 Myocardial Infarction in the Emergency Unit.

Putot A, Derrida SB, Zeller M, Avondo A, Ray P, Manckoundia P, Cottin Y.

Am J Med. 2018 Oct;131(10):1209-1219. doi: 10.1016/j.amjmed.2018.04.032. Epub 2018 Jun 19.

PMID:
29753793
36.

Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.

Auffret V, Cottin Y, Leurent G, Gilard M, Beer JC, Zabalawi A, Chagué F, Filippi E, Brunet D, Hacot JP, Brunel P, Mejri M, Lorgis L, Rouault G, Druelles P, Cornily JC, Didier R, Bot E, Boulanger B, Coudert I, Loirat A, Bedossa M, Boulmier D, Maza M, Le Guellec M, Puri R, Zeller M, Le Breton H; ORBI and RICO Working Groups.

Eur Heart J. 2018 Jun 7;39(22):2090-2102. doi: 10.1093/eurheartj/ehy127.

PMID:
29554243
37.

Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction.

Grimaldi-Bensouda L, Danchin N, Dallongeville J, Falissard B, Furber A, Cottin Y, Bonello L, Morel O, Leclercq F, Puymirat E, Ghanem F, Delarche N, Benichou J, Abenhaim L; PGRx-Acute Coronary Syndrome Study Group.

Heart. 2018 Oct;104(19):1583-1592. doi: 10.1136/heartjnl-2017-312534. Epub 2018 Mar 13.

PMID:
29535227
38.

Influence of gender on delays and early mortality in ST-segment elevation myocardial infarction: Insight from the first French Metaregistry, 2005-2012 patient-level pooled analysis.

Manzo-Silberman S, Couturaud F, Charpentier S, Auffret V, El Khoury C, Le Breton H, Belle L, Marlière S, Zeller M, Cottin Y, Danchin N, Simon T, Schiele F, Gilard M.

Int J Cardiol. 2018 Jul 1;262:1-8. doi: 10.1016/j.ijcard.2018.02.044. Epub 2018 Feb 13.

39.

Redox Functions of Heme Oxygenase-1 and Biliverdin Reductase in Diabetes.

Rochette L, Zeller M, Cottin Y, Vergely C.

Trends Endocrinol Metab. 2018 Feb;29(2):74-85. doi: 10.1016/j.tem.2017.11.005. Epub 2017 Dec 14. Review.

PMID:
29249571
40.

Blood Transfusion in Elderly Patients with Acute Myocardial Infarction: Data from the RICO Survey.

Putot A, Zeller M, Perrin S, Beer JC, Ravisy J, Guenancia C, Robert R, Manckoundia P, Cottin Y.

Am J Med. 2018 Apr;131(4):422-429.e4. doi: 10.1016/j.amjmed.2017.09.027. Epub 2017 Oct 10.

PMID:
29030059
41.

[Screening and clinical implications of silent atrial fibrillation].

Guenancia C, Garnier F, Mouhat B, Béjot Y, Maillot N, Fichot M, Fauchier L, Cottin Y.

Rev Med Interne. 2018 Jul;39(7):574-579. doi: 10.1016/j.revmed.2017.08.006. Epub 2017 Sep 21. Review. French.

PMID:
28942937
42.

Hypoxia and heart regeneration: A new paradoxical approach for cardioprotection.

Rochette L, Malka G, Cottin Y.

Arch Cardiovasc Dis. 2017 Oct;110(10):503-507. doi: 10.1016/j.acvd.2017.06.001. Epub 2017 Sep 13. Review. No abstract available.

43.

The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases.

Rochette L, Meloux A, Rigal E, Zeller M, Cottin Y, Vergely C.

Pharmacol Ther. 2018 Feb;182:115-132. doi: 10.1016/j.pharmthera.2017.08.015. Epub 2017 Sep 1. Review.

PMID:
28867452
44.

Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015.

Puymirat E, Simon T, Cayla G, Cottin Y, Elbaz M, Coste P, Lemesle G, Motreff P, Popovic B, Khalife K, Labèque JN, Perret T, Le Ray C, Orion L, Jouve B, Blanchard D, Peycher P, Silvain J, Steg PG, Goldstein P, Guéret P, Belle L, Aissaoui N, Ferrières J, Schiele F, Danchin N; USIK, USIC 2000, and FAST-MI investigators.

Circulation. 2017 Nov 14;136(20):1908-1919. doi: 10.1161/CIRCULATIONAHA.117.030798. Epub 2017 Aug 27.

PMID:
28844989
45.

Impact of the dynamic and static component of the sport practised for electrocardiogram analysis in screening athletes.

Maillot N, Guenancia C, Yameogo NV, Gudjoncik A, Garnier F, Lorgis L, Chagué F, Cottin Y.

Scand J Med Sci Sports. 2018 Feb;28(2):575-584. doi: 10.1111/sms.12949. Epub 2017 Aug 11.

PMID:
28730749
46.

Relation between high levels of myeloperoxidase in the culprit artery and microvascular obstruction, infarct size and reverse remodeling in ST-elevation myocardial infarction.

Stamboul K, Zeller M, Rochette L, Cottin Y, Cochet A, Leclercq T, Porot G, Guenancia C, Fichot M, Maillot N, Vergely C, Lorgis L.

PLoS One. 2017 Jul 13;12(7):e0179929. doi: 10.1371/journal.pone.0179929. eCollection 2017.

47.

French Registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction 2015 (FAST-MI 2015). Design and baseline data.

Belle L, Cayla G, Cottin Y, Coste P, Khalife K, Labèque JN, Farah B, Perret T, Goldstein P, Gueugniaud PY, Braun F, Gauthier J, Gilard M, Le Heuzey JY, Naccache N, Drouet E, Bataille V, Ferrières J, Puymirat E, Schiele F, Simon T, Danchin N; FAST-MI 2015 investigators.

Arch Cardiovasc Dis. 2017 Jun - Jul;110(6-7):366-378. doi: 10.1016/j.acvd.2017.05.001. Epub 2017 Jun 21.

48.

Implications of excess weight in the cardiotoxicity of anthracyclines and trastuzumab in breast cancer.

Guenancia C, Ladoire S, Ghiringelli F, Rochette L, Vergely C, Cottin Y.

Arch Cardiovasc Dis. 2017 Feb;110(2):69-71. doi: 10.1016/j.acvd.2016.12.004. Epub 2017 Feb 16. No abstract available.

49.

Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction.

Lorin J, Guilland JC, Stamboul K, Guenancia C, Cottin Y, Rochette L, Vergely C, Zeller M.

PLoS One. 2017 Jan 26;12(1):e0169979. doi: 10.1371/journal.pone.0169979. eCollection 2017.

50.

Reply to Z. Cheraghi et al.

Guenancia C, Cottin Y, Vergely C, Lebfevre A.

J Clin Oncol. 2017 Mar 10;35(8):924-925. doi: 10.1200/JCO.2016.71.3842. Epub 2017 Jan 23. No abstract available. Erratum in: J Clin Oncol. 2017 Aug 1;35(22):2590.

PMID:
28113011

Supplemental Content

Loading ...
Support Center